161 related articles for article (PubMed ID: 26335183)
1. p21(WAF1) is component of a positive feedback loop that maintains the p53 transcriptional program.
Pang LY; Scott M; Hayward RL; Mohammed H; Whitelaw CB; Smith GC; Hupp TR
Cell Cycle; 2011 Mar; 10(6):932-50. PubMed ID: 21368573
[TBL] [Abstract][Full Text] [Related]
2. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics.
Whitnall M; Howard J; Ponka P; Richardson DR
Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14901-6. PubMed ID: 17003122
[TBL] [Abstract][Full Text] [Related]
3. Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure.
Zhang S; El-Deiry WS
Oncotarget; 2024 May; 15():275-284. PubMed ID: 38709242
[TBL] [Abstract][Full Text] [Related]
4. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.
Gong W; Russell M; Suzuki K; Riabowol K
Mol Cell Biol; 2006 Apr; 26(8):2947-54. PubMed ID: 16581770
[TBL] [Abstract][Full Text] [Related]
5. The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity.
Park KC; Dharmasivam M; Richardson DR
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948029
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of the p53-DNA Complex by the Nuclear Protein Dmp1α.
Kendig RD; Kai F; Fry EA; Inoue K
Cancer Invest; 2017 May; 35(5):301-312. PubMed ID: 28406729
[TBL] [Abstract][Full Text] [Related]
7. Intracellular colocalization and interaction of IGF-binding protein-2 with the cyclin-dependent kinase inhibitor p21CIP1/WAF1 during growth inhibition.
Terrien X; Bonvin E; Corroyer S; Tabary O; Clement A; Henrion Caude A
Biochem J; 2005 Dec; 392(Pt 3):457-65. PubMed ID: 16131350
[TBL] [Abstract][Full Text] [Related]
8. Diphthamide deficiency promotes association of eEF2 with p53 to induce p21 expression and neural crest defects.
Shi Y; Huang D; Song C; Cao R; Wang Z; Wang D; Zhao L; Xu X; Lu C; Xiong F; Zhao H; Li S; Zhou Q; Luo S; Hu D; Zhang Y; Wang C; Shen Y; Su W; Wu Y; Schmitz K; Wei S; Song W
Nat Commun; 2024 Apr; 15(1):3301. PubMed ID: 38671004
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis of polyploid giant cancer cells and their progeny reveals a functional role for p21 in polyploidization and depolyploidization.
White-Gilbertson S; Lu P; Saatci O; Sahin O; Delaney JR; Ogretmen B; Voelkel-Johnson C
J Biol Chem; 2024 Apr; 300(4):107136. PubMed ID: 38447798
[TBL] [Abstract][Full Text] [Related]
10. Sex-Specific Associations of
Ward SV; Autuori I; Luo L; LaPilla E; Yoo S; Sharma A; Busam KJ; Olilla DW; Dwyer T; Anton-Culver H; Zanetti R; Sacchetto L; Cust AE; Gallagher RP; Kanetsky PA; Rosso S; Begg CB; Berwick M; Thomas NE; Orlow I;
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345045
[No Abstract] [Full Text] [Related]
11. Reversing oncogenic transformation with iron chelation.
Abdelaal G; Veuger S
Oncotarget; 2021 Jan; 12(2):106-124. PubMed ID: 33520115
[TBL] [Abstract][Full Text] [Related]
12. Deferasirox-Dependent Iron Chelation Enhances Mitochondrial Dysfunction and Restores p53 Signaling by Stabilization of p53 Family Members in Leukemic Cells.
Calabrese C; Panuzzo C; Stanga S; Andreani G; Ravera S; Maglione A; Pironi L; Petiti J; Shahzad Ali MS; Scaravaglio P; Napoli F; Fava C; De Gobbi M; Frassoni F; Saglio G; Bracco E; Pergolizzi B; Cilloni D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081324
[TBL] [Abstract][Full Text] [Related]
13. Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.
Menezes SV; Sahni S; Kovacevic Z; Richardson DR
J Biol Chem; 2017 Aug; 292(31):12772-12782. PubMed ID: 28615452
[TBL] [Abstract][Full Text] [Related]
14. Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.
Moussa RS; Kovacevic Z; Richardson DR
Oncotarget; 2015 Oct; 6(30):29694-711. PubMed ID: 26335183
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of the cyclin-dependent kinase inhibitor, p21
Moussa RS; Kovacevic Z; Bae DH; Lane DJR; Richardson DR
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):761-774. PubMed ID: 29032246
[TBL] [Abstract][Full Text] [Related]
16. The metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), upregulates p21 via p53-independent mechanisms.
Kovacevic Z; Sivagurunathan S; Mangs H; Chikhani S; Zhang D; Richardson DR
Carcinogenesis; 2011 May; 32(5):732-40. PubMed ID: 21398495
[TBL] [Abstract][Full Text] [Related]
17. Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation.
Le NT; Richardson DR
Carcinogenesis; 2003 Jun; 24(6):1045-58. PubMed ID: 12807743
[TBL] [Abstract][Full Text] [Related]
18. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy.
Fang BA; Kovačević Ž; Park KC; Kalinowski DS; Jansson PJ; Lane DJ; Sahni S; Richardson DR
Biochim Biophys Acta; 2014 Jan; 1845(1):1-19. PubMed ID: 24269900
[TBL] [Abstract][Full Text] [Related]
19. The role of iron in cell cycle progression and the proliferation of neoplastic cells.
Le NT; Richardson DR
Biochim Biophys Acta; 2002 Oct; 1603(1):31-46. PubMed ID: 12242109
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
